Datavyne, Inc. — SEC Form D Filing

Datavyne, Inc. filed an SEC Form D on May 20, 2026, reporting $55K raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
May 20, 2026
Amount reported
$55K
Round stage
Seed
Industry
Health Care
Website
https://datavyne.solutions/

What the company does

Securities: Equity, SAFE. Revenue: $1 - $1,000,000. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

The process of Clinical Primary Source Verification is manual, involving spreadsheets and valuable clinician hours, which could be better spent on clinical work.

Solution

Datavyne provides an automated solution called Trellis, which replaces manual chart chasing with a workflow-driven process, centralizes source documentation, surfaces data quality issues, and produces audit-ready trails.

Why now

There is an increasing need for efficient, compliant, and accurate verification methods in healthcare operations amidst regulatory pressures.

Verdict

Investors backed Datavyne because they recognized a critical inefficiency in clinical operations that demanded automation, not because the founder’s operational background was robust. By offering a streamlined solution to a common problem, they bet on the rising regulatory need for compliance and efficiency in healthcare workflows. However, the limited upside lies in its reliance on already crowded themes in medical automation, which could dilute differentiation over time if the competitive landscape shifts quickly.

Source: SEC EDGAR Form D filing